An Act to direct the Secretary of Health and Human Resources to convene a stakeholder work group to conduct a comprehensive evaluation of the impacts of the federal 340B Drug Pricing Program within the Commonwealth; report.
Impact
The passage of SB278 would impact the state's approach to health policy by enhancing oversight and transparency concerning the 340B Drug Pricing Program. By evaluating how these programs function within the Commonwealth, and exploring the relationship between covered entities and contract pharmacies, the bill emphasizes ensuring these services benefit low-income and underserved populations. Furthermore, the bill could lead to the development of new governance measures that might affect how pharmacies operate under the program and their accountability to state authorities.
Summary
SB278 aims to convene a comprehensive stakeholder work group directed by the Secretary of Health and Human Resources in Virginia to evaluate the impacts of the federal 340B Drug Pricing Program. This legislation is significant as it seeks to analyze various aspects of the program, focusing on governance, transparency, and access to pharmacy services in both rural and underserved communities. The bill mandates a thorough review of the existing requirements, the number of covered entities, contract pharmacies, and potential improvements at the state level to enhance the program's effectiveness.
Sentiment
The sentiment around SB278 appears to be cautiously positive. Advocates see the evaluation work group as a necessary step towards improving healthcare access and pharmacy services for vulnerable populations, indicating a proactive legislative stance on health equity. While the overall tone is supportive, there are concerns regarding the complexity of the 340B program and how the findings will translate into effective policy changes that genuinely address local needs.
Contention
One of the notable points of contention regarding SB278 centers on the balance between federal requirements and the necessity for state-level oversight and transparency. Critics may raise concerns about the potential bureaucratic intricacies that could arise from more stringent governance measures. There might also be debates regarding the adequacy of the representation in the stakeholder work group and whether it sufficiently captures all necessary perspectives, particularly those of rural health providers and community pharmacies, ensuring their unique challenges are adequately addressed.
Virginia Health Workforce Development Authority; Virginia Nursing Workforce Center established; reporting and monitoring of health care workforce programs; residency slots; work group; report.